Characteristics | OS | Â | Â | DFS | ||||
---|---|---|---|---|---|---|---|---|
Before PSM | After PSM | Before PSM | After PSM | |||||
HR (95CI) | P-value | HR (95CI) | P-value | HR (95CI) | P-value | HR (95CI) | P-value | |
γ-GT ≤ 54 U/L | ||||||||
 Tumor number (Multiple vs Single) | 2.11 (1.55–2.87) | < 0.001 | 1.97 (1.33–2.93) | 0.001 | 2.07 (1.61–2.65) | < 0.001 | 2.18 (1.59–2.98) | < 0.001 |
 Tumor diameter (cm) | 1.11 (1.07–1.15) | < 0.001 | 1.11 (1.05–1.17) | < 0.001 | 1.08 (1.04–1.12) | < 0.001 | 1.08 (1.03–1.13) | 0.003 |
 Capsule (Absent vs Present) | 1.36 (1.02–1.81) | 0.039 | 1.41 (0.95–2.09) | 0.085 | – | – | – | – |
 MVI (Absent vs Present) | 1.58 (1.22–2.06) | 0.001 | 1.57 (1.10–2.26) | 0.014 | 1.44 (1.16–1.79) | 0.001 | 1.45 (1.08–1.95) | 0.014 |
 PA-TACE (Yes vs No) | 0.85 (0.65–1.11) | 0.222 | 0.89 (0.64–1.23) | 0.471 | 0.86 (0.69–1.08) | 0.190 | 0.91 (0.71–1.18) | 0.483 |
γ-GT > 54 U/L | ||||||||
 TBil (μmol/L) | 1.01 (1.00–1.03) | 0.036 | 1.02 (1.01–1.04) | 0.009 | 1.01 (1.00–1.03) | 0.028 | 1.03 (1.01–1.05) | < 0.001 |
 AFP (> 400 vs 400 ng/mL) | 1.71 (1.39–2.10) | < 0.001 | 1.71 (1.32–2.22) | < 0.001 | 1.43 (1.20–1.71) | < 0.001 | 1.47 (1.18–1.84) | 0.001 |
 Tumor number (Multiple vs Single) | – | – | – | – | 1.25 (1.01–1.56) | 0.042 | 1.08 (0.82–1.42) | 0.589 |
 Tumor diameter (cm) | 1.06 (1.04–1.09) | < 0.001 | 1.07 (1.04–1.10) | < 0.001 | 1.03 (1.01–1.05) | 0.008 | 1.04 (1.01–1.06) | 0.005 |
 Capsule (Absent vs Present) | 1.33 (1.05–1.68) | 0.019 | 1.43 (1.05–1.95) | 0.024 | – | – | – | – |
 MVI (Absent vs Present) | 1.43 (1.14–1.79) | 0.002 | 1.21 (0.89–1.64) | 0.219 | 1.37 (1.13–1.65) | 0.001 | 1.19 (0.92–1.54) | 0.174 |
 PA-TACE (Yes vs No) | 0.69 (0.55–0.86) | 0.001 | 0.66 (0.52–0.85) | 0.001 | 0.76 (0.63–0.91) | 0.003 | 0.74 (0.60–0.92) | 0.006 |